Sign inJoin waitlistJoin the waitlist

Ajay Nooka

Physician · Emory University School of Medicine

Credentials: · · · · · · ·

History

Emory University School of Medicine
Present

Hematology and Medical Oncology
Emory University School of Medicine
2008–2011
Internal Medicine
Canton Medical Education Foundation
2005–2008
Dr. N.T.R University of Health Sciences
1996–2000

Research

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
New England Journal of Medicine · 2016 · 1,242 citations
Teclistamab in Relapsed or Refractory Multiple Myeloma
New England Journal of Medicine · 2022 · 1,060 citations
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
The Lancet Oncology · 2020 · 657 citations

Sagar Lonial
109 papers
Jonathan Kaufman
66 papers
Madhav Dhodapkar
37 papers
Craig Hofmeister
34 papers
Nisha Joseph
34 papers · 6 as a fellow
Vikas Gupta
32 papers · 2 as a fellow
Saad Usmani
23 papers
Ajai Chari
22 papers
LH
Leonard Heffner
19 papers
Christopher Flowers
17 papers
Edmund Waller
17 papers
Ravi Vij
16 papers

Clinical trials

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
Principal investigator · Recruiting · Phase 2
Emory University
2022–2028
Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy
Principal investigator · Withdrawn · Phase 2
Emory University
2022–2024
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
Principal investigator · Withdrawn · Phase 3
Emory University
2020
Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Principal investigator · Unknown · Phase 2
Emory University
2019–2026